Spaero
8 known investors
Spaero Bio builds technology for scientists to automate life science experiments that are currently performed by hand.
Also known as Spaero Bio
Investors · 8
Company profile
researched Aug 2026Spaero (Spaero Bio) develops technology that allows scientists to automate laboratory experiments directly and quickly, addressing the manual execution of experiments that acts as a bottleneck in life science research and development.
The company is a member of Greentown Labs, where it is listed under the Resiliency + Adaptation industry category with a founding year of 2020. It also maintains a presence on YouTube under the name Spaero Bio.
▸Full profile — technology, go-to-market
Technology
Automation of laboratory experiments, intended to let researchers directly and rapidly automate procedures otherwise carried out by hand.
Go-to-market
Scientists and life science research and development organizations that currently perform experiments manually.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 1
launches, deals, and filingsSpaero Bio is listed as a member company of Greentown Labs, categorized under the Resiliency + Adaptation industry, with a founding year of 2020.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- Spaero Bio - Greentown Labsgreentownlabs.com · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Spaero do?
- Spaero Bio builds technology for scientists to automate life science experiments that are currently performed by hand.
- Who are Spaero's investors?
- Spaero's investors include Acequia Capital (AceCap), AIX Ventures, AlleyCorp, Compound, Spacecadet Ventures, Alley Robotics Ventures, BlueYard Capital, Cantos Ventures.